From: Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration
Factor
Adjusted ODDS ratio
95% CI
P-value
Very low-dose (75 mg twice daily)
6.88
1.67–28.3
0.008*
H: Hypertension
2.25
0.83–6.12
0.110
A: Aged 75 or older
2.76
0.92–8.23
0.068
S: Stroke/TIA
2.97
1.11–7.94
0.030*